VolitionRx VolitionRx Awarded Additional $4 Million in Funding The company said that part of the funding was an unsecured loan to support the analysis of tumor DNA using a nucleosome immunoprecipitation method. VolitionRx, 4D Lifetec Partner to Combine Early Cancer Detection Assays The companies said Tuesday that they are pursuing a clinical trial utilizing their respective liquid biopsy assays on clinical samples from lung cancer patients. VolitionRx Receives $700K in Funding From Regional Government A portion of the funding, which is from the government of the Wallonia region of Belgium, is repayable over 12 years. VolitionRx, Active Motif Sign Global Sales, Distribution Agreement VolitonRx's research-use-only kits can be used to examine patterns in circulating nucleosomes in disease models, preclinical testing, and clinical trials. VolitionRx Gets CE Mark for Colorectal Cancer Screening Test The test combines two previously CE marked assays that are based on the company's Nucleosomics platform for identifying and quantifying nucleosome structural features. Jun 3, 2016 VolitionRx Readying Launch of First Cancer Test Panel Using Circulating Nucelosome Technology Premium May 12, 2016 VolitionRx Launches Clinical Trial in Germany for Pancreatic Cancer Blood Test Apr 7, 2016 VolitionRx Receives CE Marking for Two Colorectal Cancer Dx Assays Sep 22, 2015 VolitionRx Receives CE Mark for Colorectal Cancer Diagnosis Assay Mar 5, 2015 VolitionRx, ImmuneHealth Collaborate on Prostate Cancer Study Feb 24, 2015 VolitionRx Acquires Nucleosome Analysis IP from Chroma Therapeutics Feb 12, 2015 VolitionRx Closes Public Offering, Raises $8.5M Feb 6, 2015 VolitionRx Begins Trading on NYSE MKT, Prices Public Offering at $3.75 per Share Breaking News Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East The Scan Should've Been Spotted Sooner Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier. For Martian Fuel Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo. To Boost Rapid Testing The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests. PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.